During the past decade, Schwerpunktpraxis Haematologie/Onkologie - Hannover conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Schwerpunktpraxis Haematologie/Onkologie - Hannover" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Schwerpunktpraxis Haematologie/Onkologie - Hannover" are "Chronic Lymphocytic Leukemia" (3 trials), "Advanced Solid Tumors or Hematologic Malignancies" (1 trials), "Lymphoma" (1 trials) and "NTRK Family Gene Mutation" (1 trials). Many other conditions were trialed in "Schwerpunktpraxis Haematologie/Onkologie - Hannover" in a lesser frequency.

Most popular intervention types in "Schwerpunktpraxis Haematologie/Onkologie - Hannover" are "Drug" (4 trials), "Biological" (1 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fludarabine" (3 trials), "Chlorambucil" (1 trials), "Fludarabine plus Cyclophosphamide" (1 trials), "cyclophosphamide" (1 trials) and "doxorubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schwerpunktpraxis Haematologie/Onkologie - Hannover" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Schwerpunktpraxis Haematologie/Onkologie - Hannover". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Schwerpunktpraxis Haematologie/Onkologie - Hannover, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schwerpunktpraxis Haematologie/Onkologie - Hannover, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".